The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...